Contributor Page
Email  |  Website  |  Articles
By Lindsay Holmes, Lee Rosebush, Lance Shea
FDA Remarks at National Industrial Hemp Council 2019 Hemp Business Summit – The Principal Associate Commissioner for Policy
By Craig Cupid
Once a company is found ineligible for DMCA safe harbor, it is vulnerable to be found liable for copyright infringement claims.
By Marc-Joseph Gansah
Last month, New Jersey Governor Phil Murphy signed into law the Jake Honig Compassionate Use Medical Cannabis Act (the Act),
By John Lewis
In Gembarski v. PartsSource, Inc. (Slip Opinion No. 2019-Ohio-3231, decided Aug. 14, 2019), the Supreme Court of Ohio clarified the standards for waiver of the right
By Amanda L. Van Hoose Garofalo
As we reported in our blog post, and our summer newsletter, in late June, the New York Legislature passed a bill that vastly changed the discrimination and harassment landscape for employers.
By Lindsay Holmes, Lee Rosebush, Lance Shea
Most recently, the states of Mississippi and Arkansas have been sued by plant-based food producers over these laws.
By Robertson D. Beckerlegge
The Trump administration, addressing efforts to curb online counterfeiting, has called for heightened collaboration, at times suggesting providing private parties with technological resources to help combat online counterfeiting.
By Joanna Wasick
Earlier this week, cease and desist orders were issued against two online investment entities, Zoptax LLC and Unocall, as part of an ongoing effort coordinated by the North American
By Simone O. Otenaike
Early this week, a multinational technology firm launched Trust Your Supplier, a new blockchain network designed to improve supplier qualification, validation
By Diana J. Stern
Late last week, a major U.S. financial services firm made headlines with several blockchain-related developments. The first relates to a credit card that will be offered
By Gregory Mersol
We've commented many times before that relatively few collective actions survive the "second stage" motion to decertify or, relatedly, an unofficial "third stage"...
By Gregory Mersol
Two years ago, we blogged a pair of cases with similar fact patterns and outcomes involving the successful use of time studies
By Craig Cupid
The most recent changes to U.S. copyright rules driven by the Digital Millennium Copyright Act (DMCA) became effective on Dec. 1, 2016.
By Lindsay Holmes
FDA Releases Q&A on Nonclinical Toxicology Studies – The FDA published a draft guidance titled "Pathology Peer Review in Nonclinical Toxicology Studies: Questions and Answers."
By Barry E. Bretschneider
In two opinions issued in the past few weeks, the Federal Circuit has shaken up two requirements of the reissue statute that most practitioners don't think about much.
Contributor's Topics